breast cancer screening device / infrared thermography_trade folder
breast cancer screening device / infrared thermography_trade folder
BRASTER® is an innovative medical device designed for in-home breast self-examination. It utilizes liquid crystal contact thermography, a technology approved by the FDA in 1982, to detect neoplastic lesions by imaging areas of increased temperature on the breast surface.
Key Features
- User-friendly mobile application for examination support.
- Algorithms for automatic interpretation of thermal images.
- Optional telemedical center access for specialist consultation.
Technology and Efficacy
The device uses dermothermal effects to image internal thermal processes on the skin. It detects hyperthermic areas indicative of neoplastic lesions. Observational studies confirm its efficacy, with a sensitivity of 81.5% and specificity of 87% in women under 50, comparable to established diagnostic methods.
Breast Cancer Context
- Breast cancer is the most diagnosed cancer in women, with increasing incidence rates.
- Early detection significantly reduces impact on life and health.
- Many affected women are not in the traditional risk group.
Examination Process
The examination is conducted at home using a smartphone or tablet, taking approximately 15 minutes. Thermograms are analyzed by IT systems, and results are available on the user's account. Recommendations for further diagnostics, such as ultrasound or mammography, are provided if necessary.
Advantages
- Time-efficient: Takes only 15 minutes.
- Safe: Painless and non-invasive.
- Comfortable: Conducted at home.
- Diagnostic Support: Complements ultrasound and mammography.
Catalog excerpts
BRASTER® – COMPLETE SYSTEM FOR INNOVATIVE IN-HOME BREAST EXAMINATION 01. Algorithms for automatic interpretation of the recorded thermal image. User-friendly application for mobile devices supporting the examination. Telemedical centre – optional access to qualified specialists. BRASTER® uses the technology called a liquid crystal contact thermography which is based on medical thermography an imaging method approved in 1982 by the American Food and Drug Administration. Innovative medical device for monthlybreast self-examination. The liquid crystal contact thermography allows for active imaging of the breast function. Thanks to the liquid crystal contact thermography, BRASTER® is able to detect neoplastic lesions in the breast as due to uncontrolled reproduction of mutated cells and the development of a dense capillary network these lesions are imaged as areas of increased temperature (hyperthermia) The technology is based on the dermothermal effect and consists in imaging the internal thermal processes recorded on the skin surface. THE EFFICACY OF THE LIQUID CRYSTAL CONTACT THERMOGRAPHY AS A TECHNOLOGY SUPPORTING THE IMAGING DIAGNOSTICS OF THE MAMMARY GLAND HAS BEEN CONFIRMED IN OBSERVATIONAL STUDIES. The examination with Braster® shall not replace the need for other diagnostic methods currently used in the clinical practice. Join the revolution in breast self-examination! Discover a revolutionary medical device for in-home breast examination… availa
Open the catalog to page 1
WHAT MOST WOMEN DON’T KNOW ABOUT THE BREAST CANCER? LEARN THE COURSE OF A BREAST SELF-EXAMINATION WITH BRASTER® The sooner you detect the cancer, the less it affects your life and health1). 3/4 of the women suffering from breast cancer were not in the risk group2). Younger and younger women develop breast cancer, and the disease became an epidemic in the developing and developed countries3). Breast cancer is the most commonly diagnosed type of cancer in women4). Every 19 seconds a case of breast cancer is diagnosed5). Every 60 seconds a woman dies from breast cancer6). It is estimated that by...
Open the catalog to page 2